Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Volume 20, 2019 - Issue 3-4
Submit an article Journal homepage
5,515
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Predicting the future of ALS: the impact of demographic change and potential new treatments on the prevalence of ALS in the United Kingdom, 2020–2116

Alison GowlandDepartment of Basic and Clinical Neuroscience, King’s College London, Maurice Wohl Clinical Neuroscience Institute, London, UK, View further author information
,
Sarah Opie-MartinDepartment of Basic and Clinical Neuroscience, King’s College London, Maurice Wohl Clinical Neuroscience Institute, London, UK, View further author information
,
Kirsten M. ScottDepartment of Clinical Neuroscience, University of Cambridge, Cambridge, UK, View further author information
,
Ashley R. JonesDepartment of Basic and Clinical Neuroscience, King’s College London, Maurice Wohl Clinical Neuroscience Institute, London, UK, View further author information
,
Puja R. MehtaDepartment of Basic and Clinical Neuroscience, King’s College London, Maurice Wohl Clinical Neuroscience Institute, London, UK, ;King’s College Hospital, London, UK, View further author information
,
Christine J. BattsKent and Canterbury Hospital, East Kent Hospital NHS University Foundation Trust, Canterbury, UK, View further author information
,
Cathy M. EllisKing’s College Hospital, London, UK, View further author information
,
P. Nigel LeighDepartment of Neuroscience, Brighton and Sussex Medical School, Trafford Centre for Biomedical Research, University of Sussex, Brighton, UK, and View further author information
,
Christopher E. ShawUnited Kingdom Dementia Research Institute, Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UKORCID Iconhttp://orcid.org/0000-0003-0251-0146View further author information
ORCID Icon,
Jemeen SreedharanDepartment of Basic and Clinical Neuroscience, King’s College London, Maurice Wohl Clinical Neuroscience Institute, London, UK, ORCID Iconhttp://orcid.org/0000-0002-8682-6844View further author information
ORCID Icon &
Ammar Al-ChalabiDepartment of Basic and Clinical Neuroscience, King’s College London, Maurice Wohl Clinical Neuroscience Institute, London, UK, ;King’s College Hospital, London, UK, Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-4924-7712View further author information
ORCID Icon show all
Pages 264-274 | Received 16 Oct 2018, Accepted 17 Feb 2019, Published online: 09 Apr 2019

Related Research Data

Projected increase in amyotrophic lateral sclerosis from 2015 to 2040.
Source: Springer Science and Business Media LLC
Socioeconomic costs of amyotrophic lateral sclerosis according to staging system
Source: Informa UK Limited
Incidence of amyotrophic lateral sclerosis in three counties in western Washington state
Source: Ovid Technologies (Wolters Kluwer Health)
Amyotrophic lateral sclerosis in South-East England: a population-based study. The South-East England register for amyotrophic lateral sclerosis (SEALS Registry).
Source: S. Karger AG
A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
Source: Massachusetts Medical Society
Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial
Source: Elsevier BV
The Piemonte and Valle d’Aosta Register
Source: American Medical Association (AMA)
Incidence of amyotrophic lateral sclerosis in Europe
Source: BMJ
What causes amyotrophic lateral sclerosis
Source: F1000 Research Ltd

Linking provided by 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.